Zobrazeno 1 - 10
of 22
pro vyhledávání: '"N Giacomi"'
Autor:
N. Giacomi, S. Vigo, MP Dominguez, F. Marmissolle, M. Sansano, P. Price, G Zapata Caamaño, ML Lujan, E Menna, A. Mainella
Publikováno v:
Poster.
Introduction In Argentina 18.000 new cases of breast cancer (BC) are diagnosed each year and it is the commonest cause of cancer death in women reaching 5600 deaths per year. In postmenopausal women with advanced or metastatic estrogen receptor-(ER)
Autor:
ML Lujan, P. Price, G Zapata Caamaño, E Menna, F. Marmissolle, M. Sansano, MP Dominguez, A. Mainella, N. Giacomi, S. Vigo
Publikováno v:
ePoster.
Introduction/Background In Argentina, 18.000 new cases of breast cancer are diagnosed each year and it is the commonest cause of cancer death in women reaching 5600 deaths per year. About 70% of all breast cancers are estrogen receptor-(ER) positive.
Autor:
Enrique Roca, Fernando Sanchez Loria, Moisés Rosenberg, Enzo Dominichini, N. Giacomi, Mariano Dioca, Veronica Pesce, Oscar Andriani, Mirta Kujaruk, Analia Caino, Claudia Poleri, Paola Price, Gabriel Gondolesi, Victor Zamora, Juan Manuel O'Connor, Karina Patané, Claudia Bestani, Alejandro Pairola, Ana Cabanne, Gustavo Podestá, Guillermo Mendez, C. Martin, Javier Mariani, Eduardo Huertas, Susana Belli, F. Marmissolle, Patricia Parma
Publikováno v:
Molecular and Clinical Oncology. 2:673-684
Neuroendocrine tumors (NET) include a spectrum of malignancies arising from neuroendocrine cells throughout the body. The objective of this clinical investigation of retrospectively and prospectively collected data was to describe the prevalence, dem
Autor:
Sandra O. Demichelis, María Virginia Croce, Amada Segal-Eiras, N. Giacomi, A. Zwenger, Luciano Cermignani
Publikováno v:
Cancer Research. 72:P3-07
In Argentina, there are no studies evaluating neither breast cancer screening nor risk and prognostic factors in relation to socioeconomic status among women in metropolitan areas. Taking into account that Argentina presents social and economical dis
Autor:
J. O’Connor, E. Roca, N. Giacomi, Claudia Bestani, E. Domenichini, Ana Cabanne, R. Salanova, Guillermo Mendez, V. Zamora, F. Marmissolle
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 42(3)
Introduction Somatostatin receptors are expressed in a large number of human tumours. The somatostatin receptors types 1–5 expression in a series including 100 gastro-entero-pancreatic endocrine tumours were analysed. Methods From a prospectively b
Autor:
Claudia Bestani, Enrique Roca, N. Giacomi, Guillermo Mendez, Veronica Pesce, E. Domenichini, Victor Zamora, Juan Manuel O Connor, Ana Cabanne, F. Marmissolle, Matías Chacón, Patricia Parma, Susana Belli, Martín Angel
Publikováno v:
Journal of Clinical Oncology. 33:255-255
255 Background: Grade 2 (G2) Neuroendocrine tumors (NETs), of the digestive tract is a heterogeneous group of tumors. Several treatment options including chemotherapy and target therapy are available, but there is a lack of prospective trials assessi
Autor:
Veronica Pesce, N. Giacomi, E. Domenichini, Susana Belli, F. Marmissolle, J. O’Connor, Victor Zamora, Guillermo Mendez, M. Chacon, Claudia Bestani, Ana Cabanne, Enrique Roca
Publikováno v:
Journal of Clinical Oncology. 30:e14598-e14598
e14598 Background: Somatostatin receptor expression (SSTR), mainly subtypes 2 and 5, is a feature of well differentiated GEP-NETs. Such expression has a prognostic and predictive value for the use of somatostatin analogs.Ki 67, present during the cyc
Autor:
Sandra O. Demichelis, María Virginia Croce, Amada Segal-Eiras, N. Giacomi, M. Isla-Larrian, Luciano Cermignani
Publikováno v:
European Journal of Cancer Supplements. 8:145
Autor:
F. Marmissolle, A. Mainella, N. Giacomi, P. Price, M. Sansano, S. Vigo, L. Lujan, M. Antonelli, F. Mohamed
Publikováno v:
Journal of Clinical Oncology. 27:e11634-e11634
e11634 Background: Breast cancer (BC) rarely occurs in young women. Presentation, behavior and prognosis of BC in such patients (pts), when compared with older women, are unclear. It is believed that tumor is more aggressive in biologic nature in thi
Autor:
F. Marmissolle, M. Lamelza, N. Giacomi, A. Mainella, M. Antonelli, M. Sansano, S. Vigo, J. J. Valerga Martin, F. Mohamed, P. Price
Publikováno v:
Journal of Clinical Oncology. 26:22162-22162
22162 Background: c-erb-B2 is amplified in approximately 18–20% of breast cancers (BC). Her2 overexpression represents the determining factor for the potential use of trastuzumab. Immunohistochemis...